News
PULM
--
0.00%
--
Pulmatrix announces pipeline update
Pulmatrix ([[PULM]] -2.5%) update highlights:The company plans to commence patient dosing for PUR1800 Phase 1b trial in Q1 2021, and expects both the Phase 1b and 6-month toxicology data in
Seekingalpha · 2h ago
Pulmatrix Reports Progress On Product Pipeline
LEXINGTON, Mass., Sept. 22, 2020 /PRNewswire/ --Pulmatrix, Inc. (NASDAQ:PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and
Benzinga · 9h ago
Pulmatrix EPS beats by $0.33
Pulmatrix (NASDAQ:PULM): Q2 GAAP EPS of -$0.05 beats by $0.33. Revenue of $3.5M (-27.4% Y/Y) Press Release
seekingalpha · 08/07 18:09
Pulmatrix Reports Q2 2020 Results and Business Updates
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today reports its Q2 2020 financial results and pr
PR Newswire · 08/07 13:00
ALT, VERI, BBBY and MHK among midday movers
Seeking Alpha - Article · 07/09 16:39
Sensory Cloud to launch an OTC nasal hygiene product in September 2020
Seeking Alpha - Article · 07/08 13:38
Pulmatrix Announces Progress by Sensory Cloud Toward Commercial Launch of FEND in Fall 2020, an OTC Nasal Hygiene Product Designed to Suppress Exhaled Airborne Particles
PR Newswire · 07/08 13:30
Pulmatrix Announces Progress By Sensory Cloud Toward Commercial Launch Of FEND In Fall 2020, An OTC Nasal Hygiene Product Designed To Suppress Exhaled Airborne Particles
Pulmatrix's Partner Sensory Cloud to Conduct Worldwide Marketing Distribution Pulmatrix to Receive Escalating Royalties upon Commencement of Sales LEXINGTON, Mass., July 8, 2020 /PRNewswire/ -- Pulmatrix, Inc.
Benzinga · 07/08 12:34
Pulmatrix Announces Changes to Board of Directors
PR Newswire · 06/26 14:00
Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually
PR Newswire · 05/27 14:00
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.)
Benzinga · 05/21 12:01
Stocks That Hit 52-Week Highs On Wednesday
During Wednesday's morning session, 85 stocks hit new 52-week highs.
Benzinga · 05/20 14:38
Pulmatrix Reports Q1 2020 Results
PR Newswire · 05/14 14:00
Pulmatrix Q1 EPS $(0.230) Up From $(0.660) YoY, Sales $2.762M
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.230) per share. This is a 65.15 percent increase over losses of $(0.660) per share from the same period last year. The company reported $2.762 million in sales
Benzinga · 05/14 13:01
Healthcare Pro Steven Boyd Is Gobbling Up These 3 Stocks
TipRanks · 04/29 15:02
CNXM, ERJ among premarket losers
Seeking Alpha - Article · 04/27 13:13
Pulmatrix 8-K Shows Director Michael Higgins To Succeed Mark Iwicki As Chair
Benzinga · 04/22 17:10
Mid-Afternoon Market Update: Dow Climbs 350 Points; Tronox Holdings Shares Spike Higher
Toward the end of trading Friday, the Dow traded up 1.5% to 23,890.31 while the NASDAQ rose 0.05% to 8,536.23. The S&P also rose, gaining 1.31% to 2,836.24.
Benzinga · 04/17 18:46
AMC, TRNX, RDHL and MBRX among midday movers
Seeking Alpha - Article · 04/17 16:43
Mid-Day Market Update: Crude Oil Down Over 7%; Stein Mart Shares Plunge
Midway through trading Friday, the Dow traded up 1.47% to 23883.41 while the NASDAQ rose 0.49% to 8574.36. The S&P also rose, gaining 1.33% to 2,836.68.
Benzinga · 04/17 16:17